Shandong Teamgene Technology Co. Ltd. A (603151) — Capital Reinvestment Ratio
Shandong Teamgene Technology Co. Ltd. A (603151) has a Capital Reinvestment Ratio of 2.92x as of December 2022, meaning it reinvests 3% of its operating cash flow (CN¥59.07 Million) in capital expenditures (CN¥172.41 Million). See 603151 equity to assets ratio to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Shandong Teamgene Technology Co. Ltd. A Capital Reinvestment Ratio (2020–2022)
This chart tracks Shandong Teamgene Technology Co. Ltd. A's Capital Reinvestment Ratio across 3 annual periods. Check Shandong Teamgene Technology Co. Ltd. A total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Shandong Teamgene Technology Co. Ltd. A (2020–2022)
Year-by-year Capital Reinvestment Ratio for Shandong Teamgene Technology Co. Ltd. A from 2020 to 2022. For live market cap and broader valuation context, see market cap of Shandong Teamgene Technology Co. Ltd. A.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 2.92x | CN¥59.07 Million | CN¥172.41 Million | ▲ +294.4% |
| 2021 | 0.74x | CN¥131.51 Million | CN¥97.31 Million | ▲ +443.7% |
| 2020 | 0.14x | CN¥169.11 Million | CN¥23.02 Million | — |